Products Categories
    Product Certification&
    Enterprise Certification

  • Mr.zhang wenfa
    Tel: +86-556-5800026

  • Ms.Olivia Liu
    Tel: 086-556-5800080

  • Mobile:+86-18133004126
  • Tel:+86-556-5800026
  • Fax:+86-556-5800026
  • Province/state:Anhui
  • City:Anqing
  • Street:Daguan Economic Development Zone of circular economy industrial park Anqing City Anhui province
  • MaxCard:
Home > Products >  producer meglitinides Prandin GlucoNorm Surepost EIPICO Repaglinide

producer meglitinides Prandin GlucoNorm Surepost EIPICO Repaglinide CAS NO.135062-02-1

  • msdsMSDS/COA Download

  • FOB Price: USD: 2,796.00-2,796.00 /Kilogram Get Latest Price
  • Min.Order: 1 Kilogram
  • Payment Terms: L/C,T/T
  • Available Specifications:

    1(1-10)Kilogram1(1-10)Kilogram

  • Product Details

Keywords

  • Repaglinide
  • API
  • chemical

Quick Details

  • ProName: producer meglitinides Prandin GlucoNo...
  • CasNo: 135062-02-1
  • Molecular Formula: C27H36N2O4
  • Appearance: White or almost white crystalline powd...
  • Application: 135062-02-1
  • ProductionCapacity: Metric Ton/Day
  • Purity: 99
  • LimitNum: 1 Kilogram

Superiority

Products:

 Repaglinide

Synonyms:

 (S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid

CAS#:

 135062-02-1

Molecular Formula:

 C27H36N2O4

Molecular Weight:

 452.59

Assay:

 ≥99.0%

EE:

 ≥99.0%

Appearance:

 White or almost white crystalline powder

Structural:

 
   
     
 

1、White or almost white crystalline powder

2、0.01-1kg/bag,5-25kg/tub;

3、500kg/Month

 

Details

Uses[edit]

Repaglinide is used for diabetes mellitus type 2.

Adverse events[edit]

Hypoglycemia, diarrhea, nausea and weight gain.

Drug interactions[edit]

Repaglinide is a major substrate of CYP3A4 and should not be administered concomitantly with gemfibrozilclarithromycin or azole antifungals such as itraconazole orketoconazole[citation needed]. Administration of both repaglinide and one or more of these drugs results in an increase in plasma concentration of repaglinide and may lead to hypoglycemia. Repaglinide should not be combined with sulfonylurea, because they have the same mechanism of action.

Contraindications[edit]

Type 1 diabetes, severe liver disease, pregnancy and lactation are contraindications.

Pharmacology[edit]

Repaglinide lowers blood glucose by stimulating the release of insulin from the pancreas. It achieves this by closing ATP-dependent potassium channels in the membrane of the beta cells. This depolarizes the beta cells, opening the cells' calcium channels, and the resulting calcium influx induces insulin secretion.

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog